Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a45a40987a9a5c4f

Jump to content

// Workers AI · dad joke modeWhat did Cefaloglycin say? "I'm an antibiotic-ly good drug.

From Wikipedia, the free encyclopedia
(Redirected from Cephaloglycin)
Cefaloglycin
Clinical data
Trade namesKafocin
License data
ATC code
  • none
Identifiers
  • (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.020.633 Edit this at Wikidata
Chemical and physical data
FormulaC18H19N3O6S
Molar mass405.43 g·mol−1
3D model (JSmol)
  • O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)[C@@H](c3ccccc3)N)COC(=O)C)C(=O)O
  • InChI=1S/C18H19N3O6S/c1-9(22)27-7-11-8-28-17-13(16(24)21(17)14(11)18(25)26)20-15(23)12(19)10-5-3-2-4-6-10/h2-6,12-13,17H,7-8,19H2,1H3,(H,20,23)(H,25,26)/t12-,13-,17-/m1/s1 checkY
  • Key:FUBBGQLTSCSAON-PBFPGSCMSA-N checkY
 X markNcheckY (what is this?)  (verify)

Cefaloglycin INN (also spelled cephaloglycin) was the first cephalosporin antibiotic to be suitable for oral administration.[1] It was sold in the United States by Eli Lilly and Company as Kafocin.[2] It was discontinued by its manufacturer, and as of 2026, no generic versions have been approved.[3]

References

[edit]
  1. ↑ "Cephaloglycin". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. Retrieved August 4, 2026.
  2. ↑ PubChem. "Cephaloglycin". pubchem.ncbi.nlm.nih.gov. Retrieved 2026-08-04.
  3. ↑ "Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book): Kafocin (NDA 050219)". U.S. Food and Drug Administration. Retrieved 4 August 2026.
[edit]
  • Wikimedia Commons logo Media related to Cefaloglycin at Wikimedia Commons